Brief: Regent Pacific Group updates on commercialisation of PSD502
18/04/2016 09:19
April 18 (Reuters) - Regent Pacific Group Ltd 0575.HK : * Says submission of type ib variation for approval of reduced fill product * Documentation is on track for submission to ema by 20 April 2016, with aim of receiving approval of variation by 30 June 2016 * Source text for Eikon ID:nHKS86rTSQ ((For more news, please click here 0575.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Regent Pacific
See all newsBrief: Regent Pacific Says SenstendTM Approved By NMPA For Premature Ejaculation In China
Brief: Regent Pacific Says Deep Longevity To Launch U.S. Expansion In Q1 2026
Brief: Regent Pacific Shall Allot And Issue 63.4 Million Shares At Hk$0.485 Per Share
Brief: Regent Pacific Announces Submission Of Senstend New Drug Application To NMPA In China
Brief: Regent Pacific Enters Manufacturing And Supply Agreement For SENSTEND